Trial intelligence / Profile preview

Evaluation of Efficacy and Clinical Pharmacokinetic Parameters of Different Nebulization Modes

NCT07633223Phase 4Completed

Sponsor
Beni Suef University
Start
Sep 2024
Primary completion
Aug 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial in asthma (2 arms), sponsored by Beni Suef University. Primary endpoints: Amount of aerosols at 1 week, Lung Bioavailability at 1 week and 1 more. Started Sep 2024; status: completed.

02

Conditions

asthma

Beyond the preview

Go deeper on NCT07633223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07633223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call